We could show a significant reduction in CD63-positive EVs after 4 and 8 weeks of ISO or SEVO treatment in comparison to the BL level, but the differences in the control group were not significant; thus, the effect could not be related to AIP. This evidence concerns the gene CD63 and autoimmune pancreatitis.